跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROLUTEX progesterone 25 mg/1.112 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PROLUTEX progesterone 25 mg/1.112 mL solution for injection vial
Approved
STANDARD
PROLUTEX progesterone 25 mg/1.112 mL solution for injection vial
Boucher & Muir Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7c551a3516f253cd
Company
Boucher & Muir Pty Ltd
Type
Standard
Approval Details
Approval Id
7c551a3516f253cd
Product Name
PROLUTEX progesterone 25 mg/1.112 mL solution for injection vial
Artg Id
393324
Artg Name
PROLUTEX progesterone 25 mg/1.112 mL solution for injection vial
Sponsor
Boucher & Muir Pty Ltd
Company Detail Path
/organization/boucher-and-muir-pty-ltd
Artg Date
2023-09-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8da73ea817fc5b958c7be1d77ff2487e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/e1f8739bcba48d3ec47042b3128a7f5c.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7c551a3516f253cd
Type
Standard
Back to TGA Approvals